New World Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
New World Advisors's REGN Position: Q2 2026 in Review
New World Advisors opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 427 shares worth $266K. The stake represents 0.05% of the portfolio and ranks #86 among its holdings. This is a return to the name: New World Advisors previously reported a position in REGN as recently as Q1 2019.
New World Advisors first reported a position in REGN in Q1 2019 and has held it in 2 quarters since. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- New World Advisors held 427 shares of Regeneron Pharmaceuticals worth $266K as of Q2 2026.
- Regeneron Pharmaceuticals was a new New World Advisors position in Q2 2026.
- Regeneron Pharmaceuticals made up 0.05% of New World Advisors's portfolio in Q2 2026, its #86 holding.
- New World Advisors first reported a position in Regeneron Pharmaceuticals in Q1 2019 and has held it in 2 quarters since.
- 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on New World Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.